BOSTON (AP) — BOSTON (AP) — Elicio Therapeutics, Inc. (ELTX) on Thursday reported a loss of $7.7 million in its fourth quarter.

The Boston-based company said it had a loss of 49 cents per share.

For the year, the company reported a loss of $39.6 million, or $2.58 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ELTX at https://www.zacks.com/ap/ELTX